Intestinal presentation of non-Hodgkin lymphoma: Case report

[1]  P. Bradley,et al.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. , 2020, International journal of surgery.

[2]  U. Farooque,et al.  Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma With Extraintestinal Areas of Peripheral T-Cell Lymphoma Involvement , 2020, Cureus.

[3]  D. Spagnolo,et al.  T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update. , 2019, Pathology.

[4]  T. Rosen.  T-Cell and NK-Cell Lymphomas , 2019, Cancer Treatment and Research.

[5]  S. Kim,et al.  A Multicenter Retrospective Analysis of Clinicopathologic Features of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma , 2018, Blood.

[6]  K. Laribi,et al.  Recent Advances in the Treatment of Peripheral T-Cell Lymphoma. , 2018, The oncologist.

[7]  Suzanne K. Lewis,et al.  Indolent T‐ and NK‐cell lymphoproliferative disorders of the gastrointestinal tract: a review and update , 2017, Hematological oncology.

[8]  L. Scott.  Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma , 2017, Drugs.

[9]  D. Chang,et al.  Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series , 2016, Gut and liver.

[10]  D. Toro,et al.  Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity? , 2015, Cancer control : journal of the Moffitt Cancer Center.

[11]  N. Chao.  Faculty Opinions recommendation of Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. , 2012 .

[12]  S. Wan,et al.  Type II Enteropathy-Associated T-Cell Lymphoma: A Distinct Aggressive Lymphoma With Frequent &ggr;&dgr; T-cell Receptor Expression , 2011, The American journal of surgical pathology.

[13]  F. Gherlinzoni,et al.  Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. , 1997, Haematologica.